Search research articles
Contact Us
Filters
Showing results (41-50 of 90) with videos related to
Page
of 9
Sort By:
La Nouvelle Presse Medicale
|
June 16, 1979
[The treatment of Cushing's syndrome by selective excision of pituitary adenoma. 3 cases (author's transl)]
J Riviere, G Manciet, P Roger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial
P F Conte, P G Giannessi, J Latreille, et al.
Journal of Medical Genetics
|
May 6, 2008
Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach
F Chibon, C Primois, J-M Bressieux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer
C T Tyrrell, P F Bruning, F May-Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)
L Mauriac, G MacGrogan, A Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
Breast Cancer Research and Treatment
|
April 26, 2012
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity
M Toulmonde, N Madranges, V Brouste, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial
J Bonneterre, L Mauriac, B Weber, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
J Bonneterre, H Coppens, L Mauriac, et al.
Chirurgie; Memoires De L'Academie De Chirurgie
|
September 30, 1998
[Results of 10 years of a randomized trial of neoadjuvant chemotherapy in breast cancers larger than 3 cm]
A Avril, A Faucher, E Bussières, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 90) with videos related to
Sort By:
Page
of 9
La Nouvelle Presse Medicale
|
June 16, 1979
[The treatment of Cushing's syndrome by selective excision of pituitary adenoma. 3 cases (author's transl)]
J Riviere, G Manciet, P Roger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial
P F Conte, P G Giannessi, J Latreille, et al.
Journal of Medical Genetics
|
May 6, 2008
Contribution of PTEN large rearrangements in Cowden disease: a multiplex amplifiable probe hybridisation (MAPH) screening approach
F Chibon, C Primois, J-M Bressieux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer
C T Tyrrell, P F Bruning, F May-Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)
L Mauriac, G MacGrogan, A Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2005
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
R Arriagada, M G Lê, M Spielmann, et al.
Breast Cancer Research and Treatment
|
April 26, 2012
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity
M Toulmonde, N Madranges, V Brouste, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1988
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial
J Bonneterre, L Mauriac, B Weber, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
J Bonneterre, H Coppens, L Mauriac, et al.
Chirurgie; Memoires De L'Academie De Chirurgie
|
September 30, 1998
[Results of 10 years of a randomized trial of neoadjuvant chemotherapy in breast cancers larger than 3 cm]
A Avril, A Faucher, E Bussières, et al.
Page
of 9